Federal Panel Votes to Consolidate Actos Bladder Cancer Lawsuits

Nadrich & Cohen LLP reports that a federal judicial panel has voted to consolidate pending Actos bladder cancer claims into a multidistrict litigation for pretrial proceedings.

Los Angeles, CA, January 5, 2012 – Plaintiffs in the Actos bladder cancer litigation have successfully moved to have the federal lawsuits consolidated into a multidistrict litigation for pretrial proceedings. The cases will be transferred to the Western District Court of Louisiana, with the Honorable Rebecca F. Doherty presiding.

Takeda Pharmaceuticals, the Japanese maker of Actos, had previously opposed the motion. The company is currently facing an estimated 3,500 lawsuits filed in state and federal courts across the country on behalf of patients who claim the drug caused serious side effects.

Actos (pioglitazone) was approved by the U.S. Food and Drug Administration in 1999 to treat Type 2 diabetes in adult patients. In September 2010, an FDA-sponsored research study indicated that prolonged exposure to pioglitazone could potentially result in an increased risk for developing bladder cancer.

In June 2011, the FDA issued an updated safety communication advising doctors and diabetes patients that taking the drug for a year or more could significantly elevate individual bladder cancer risk.

If you or a loved one was diagnosed with bladder cancer after taking Actos, you can complete a MedWatch form by visiting www.fda.gov. It is also recommended that you contact an experienced Actos bladder cancer attorney to discuss your legal rights.

Nadrich & Cohen LLP offers confidential, no-cost consultations to Actos users across the country that were harmed by the drug. Help is available by calling the firm’s injury hotline at 1-800-722-0765 or by completing an online case evaluation form at www.sideeffectactos.com.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling Actos bladder claims, Nadrich & Cohen LLP is also investigating cases involving Accutane, Avandia, Fosamax, Paxil, Zoloft, DePuy ASR Hip Recall, Zimmer Hip Recall, Wright Conserve Hips, Vaginal Mesh, Yaz, Yasmin, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan.

The time you have to file an injury claim is limited, so it’s important to act as quickly as possible to protect your rights. Call 1-800-722-0765 today to speak with a qualified personal injury expert or visit www.personalinjurylawcal.com.

###

Nadrich & Cohen LLP is a national law firm specializing in representing individuals who have been injured by defective medical devices, harmful prescription drugs, faulty products, car accidents, motorcycle accidents and dog bites. For more information, visit www.PersonalInjuryLawCal.com.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com

This release was published on openPR.